Portfolio Modifications - 08/04/2025
Novo, Grab, Hims & Palantir.
I’ve always said that fundamentals, research & convictions matter, but beating the market comes down to execution. That’s what these write-ups will be about.
I will share through them every change in my active portfolio - stocks & options, reasonings & plans, before I even hit the buttons. I won’t update DCAs, I will only share my plans & new/closed positions in these write-ups. You can follow the rest directly on savvytrader.
https://savvytrader.com/wealthyreadingspro/active
I also recently opened a Buy & Hodl portfolio on which I will DCA $4,000 every month & focus on buying the best assets I can at the best possible price, 100% focused on fundamentals & valuation, without any active management.
https://savvytrader.com/wealthyreadingspro/buyandhodl
Keep in mind that both portfolios have completely different goals and I can behave very differently on both for the same name - accumulating in the buy & hodl while selling in the active portfolio for example. Different rules apply.
My goal is to deliver alpha over the long term, not just six months under easy market conditions. If/when proven this content is valuable, it will be shared behind a paywall. No rush, though; it’ll stay free until proven valuable.
So here’s the deal: you get full transparency on my trades, right when I make them. If - and only in that case, it brings real & long-term alpha, it’ll be accessible only for a fee. I believe that’s fair enough, but feel free to provide feedback!
Nothing shared here is financial advice; we are all responsible for ourselves.
And before we start, a friendly reminder that you’ll find 15% off for any subscriptions to Fiscal.AI using my referral link - if interested.
https://fiscal.ai/?via=wealthyreadings
Active Portfolio - No change.
Option Portfolio - Closed NVO, JD & GRAB.
Hopefully Transmedics will save the actual loss strike as the position is up 70%+ since I bought in & weighted 30% of the total portfolio. This screenshot makes a srong case on the importance of capital allocation - and of not overtrading…
More focus on high convictions. Less focus on lesser ones. Working on this.
Building Cash.
I continue on my short-term narrative of building cash, hence accepting my losses on a few names as I believe it is better to raise this cash than to hold on to those at the moment.
The S&P is having a pretty nice bounce today but it is only logical after falling 3% in two trading days, but it doesn’t mean the breather is over, especially as we’re only bouncing on the EMA21, not breaking it & still under bearish divergences.
So I am using this daily strength to gather some cash from my weakest position, hoping that we’ll have better opportunities during August.
Grab.
I closed the position as the stock reintegrated its trendline. My thesis was that we’d have a positive catalyst on earnings, which didn’t happen, so I was only waiting for a green day to close the position.
That was today, so I did.
Novo.
Same story for Novo, although this trade lost almost all capital allocated to it - a very small position as I shared many times. This position wasn’t worth holding, so I gathered what was left.
Buy & Hold Portfolio.
Hims & Palantir.
I shared that I trimmed Palantir & why a few days ago, so I will share now why I did the same with Hims today - which once again are not on the SavvyTrader because I bought those positions before I opened my public portfolio.
Here is the argumentation for Palantir.
Here’s for Hims, which reports earnings tonight.
I have no specific view on those results but struggle to see what could push the stock higher - despite massive growth or news on the GLP-1 side which seems unlikely under actual conditions.
There’s a growing risk of legal actions from Novo Nordisk who intends to fight for its patents - might not happen or not win a legal battle but the noise would be enough to push the stock south.
Hims trades at the high end of its P/S range & the market did not upgrade those multiples over the last months despite great news, so I see no reasons for it to happen under actual conditions, without deep fundamental changes - which?
The stock continues to rise under bearish divergence in daily - starting in weekly, despite breaking a trendline. Not a good look before earnings. We could bounce higher if fundamentals are stronger tahn expectations, but the probabilities don’t really point towards this, so I play them.
I might be wrong, still holding a big part of my position as this is for the long term but the stock was due for a trim after more than 200% returns, and the conditions are now all met to do so.
Methods are meant to be followed.